Scientists find how COVID-19 can affect brain health
In a new study from the University of Oxford, researchers found that even a mild case of COVID-19 might have damage to the brain.
They...
Cancer and booster shot: What you need to know
Who should get an additional dose of the COVID-19 vaccine?
People with certain cancers and those who are receiving treatment that suppresses the immune system...
Previous common cold may cause worse COVID infections
At the beginning of the COVID pandemic, people were hopeful that pre-existing immunity to the common cold could protect you from COVID.
But in a...
Fractional doses of COVID-19 vaccines can bring benefits, study finds
In a new study, researchers call for the testing of fractional doses of COVID-19 vaccines to stretch the supply and accelerate global vaccination against...
Scientists develop a new drug to fight COVID-19
In a new study from the University of Münster, researchers found a new a drug candidate against SARS-CoV-2 infections.
This could constitute the basis for...
People with these mental diseases have lower COVID-19 risk
In a recent study published in JAMA Network Open, researchers found people with psychiatric disorders, including schizophrenia and mood disorders, are less likely to...
Omicron variant is three times more contagious than delta
In a new study from the University of North Carolina, researchers found that the omicron variant is three times more contagious than delta.
Remember alpha,...
Scientists find a causal link between blood group and severe COVID-19
In a new study from King's College London, researchers analyzed over 3000 proteins to identify which are causally linked to the development of severe...
Older people have more COVID-19 antibodies, study finds
With the emergence of SARS-CoV-2 variants worldwide, the pandemic’s spread is accelerating.
In a recent study published in Scientific Reports, researchers found that those who received...
All three Omicron subvariants blunt vaccine and antibody treatment effectiveness
In a new study from Columbia University, researchers found only one currently authorized antibody treatment retains its activity against all Omicron subvariants.
They also found...